Strategic Alliance for Mutual Growth

Strategic Alliance for Mutual Growth: YOKO BIOPHARM and Zhejiang Yuexi Capsule Co., Ltd. Sign Long-term Cooperation Agreement

Strategic Alliance for Mutual Growth: YUEXI CAPSULE and YOKO BIOPHARM. Sign Long-term Cooperation Agreement



Recently, YUEXI CAPSULE, a benchmark enterprise in China's empty capsule industry, officially signed a long-term strategic cooperation agreement with YOKO BIOPHARM, a well-known global supplier with 35 years of experience in pharmaceutical excipient equipment and related products. Based on their respective core strengths, the two parties have achieved resource complementarity and built a new "equipment + product" collaborative development model, helping each other expand market boundaries and realize an upgraded industrial ecosystem with mutual benefits and win-win results.







As a key player in this cooperation, YUEXI CAPSULE has grown into a powerful manufacturer in China's empty capsule sector with nearly 40 years of industry experience. Founded in 1986, the company is located near the Tianmu Mountain Scenic Area in Xinchang, Shaoxing, Zhejiang, boasting total assets of over 80 million yuan and a plant area of 16,000 square meters. It is equipped with 16 advanced automatic empty capsule production lines, with an annual production capacity of up to 11 billion pieces. The company can large-scale supply full-specification gelatin empty capsules, vegetable capsules and safety capsules ranging from size 000# to 5#, while also providing value-added services such as capsule printing and customized color matching. Adhering to strict GMP production standards and ISO 9001:2008 quality management system certification, its products have obtained multiple international certifications including US FDA and HALAL, and comply with the pharmacopoeia standards of China, the United States (USP), Britain (BP) and Europe (EP). These products are widely used in pharmaceutical preparations, health products, herbal products and other fields, and are exported to many countries and regions around the world. In addition, the company holds 93 relevant patents, forming unique competitive advantages in empty capsule production process optimization and quality control. Its newly added 4 vegetable capsule production lines are more in line with the development trend of global green pharmaceuticals.



In this strategic cooperation, the two parties have clarified the core direction of resource complementarity: YOKO BIOPHARM will give full play to its technical advantages in pharmaceutical equipment, providing YUEXI CAPSULE with a full set of high-quality capsule production machinery, as well as capsule filling and packaging equipment. Leveraging its experience in serving more than 300 cooperative enterprises worldwide and its profound understanding of intelligent and high-efficiency production needs, the equipment provided by YOKO BIOPHARM will accurately adapt to the large-scale production scenarios of YUEXI CAPSULE, helping it further improve the automation level of production lines, optimize production efficiency, and ensure the stability and consistency of product quality. This will provide strong equipment support for YUEXI CAPSULE to expand high-end markets and meet stringent international regulatory standards.







In return, YUEXI CAPSULE will stably supply YOKO BIOPHARM with full-specification, high-quality empty capsule products, covering core categories such as gelatin capsules and vegetable capsules. Relying on YUEXI CAPSULE's mature production system, sufficient production capacity reserve and multi-pharmacopoeia compliance qualifications, YOKO BIOPHARM can improve its supporting service capabilities of "equipment + excipients" through this cooperation, providing global customers with more comprehensive one-stop solutions. Especially in emerging segments such as vegetable capsules, YOKO BIOPHARM can quickly respond to market demands and enhance its core competitiveness in the global pharmaceutical supply chain.







Regarding this cooperation, the responsible persons of both parties expressed optimism about the prospects of collaborative development. The relevant person in charge of YOKO BIOPHARM pointed out that YUEXI CAPSULE's advantages in production capacity, quality and compliance are highly compatible with the company's global service network. This cooperation will fill the resource gap of YOKO BIOPHARM in the excipient supply end, realizing the extension of full-chain services from equipment to products. Wang Sanlin, general manager of YUEXI CAPSULE, said that YOKO BIOPHARM's high-end equipment and global vision will help the company upgrade its production system, break through production capacity bottlenecks, further expand its international market share, and consolidate its position in the industry.



Against the backdrop of the global pharmaceutical industry's transformation towards greenization, high efficiency and compliance, this strategic cooperation between YOKO BIOPHARM and YUEXI CAPSULE is not only an accurate docking of the advantageous resources of both parties, but also a vivid practice of upstream and downstream collaborative upgrading of the industrial chain. In the future, the two parties will take this cooperation as a starting point, continuously deepen cooperation in technical research and development, market expansion and other fields, jointly tap the growth potential of the global empty capsule and pharmaceutical equipment market, and inject new momentum into the high-quality development of the industry.